New Releases from NCBI BookshelfSatralizumab for preventing relapses in neuromyelitis optica spectrum disorders (terminated appraisal).Satralizumab for preventing relapses in neuromyelitis optica spectrum disorders (terminated appraisal).By admin / March 25, 2025 Post Content
